Meeting
2020 ASCO Virtual Scientific Program
Development of a novel liquid biopsy test to diagnose and locate gastrointestinal cancers.
Authors
Yuying Wang
BGI Genomics, Shenzhen, China
Yuying Wang , Jianchao Zheng , Zhilong Li , Ruijingfang Jiang , Jiaxi Peng , Jianlong Sun , Guanghui Yang , Xin-Rong Yang , Ao Huang , Yupeng Wang , Yuan Jie , Xuanhui Liu , Feng Gao , Xiaojian Wu , Dansong WANG , Wenchuan Wu , Wenhui Lou , Jian Zhou , Jia Fan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1557)
DOI
10.1200/JCO.2020.38.15_suppl.1557
Abstract #
1557
Poster Bd #
49
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.
First Author: Michelle Pek
Poster
2017 ASCO Annual Meeting
The mutational landscape of gastrointestinal malignancies as reflected by circulating tumor DNA.
First Author: Paul Riviere
Poster
2024 ASCO Annual Meeting
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
First Author: Huiyan Luo
Poster
2024 ASCO Annual Meeting
Clinical validation of Northstar Select, a novel liquid biopsy assay for comprehensive genomic profiling of solid tumors.
First Author: Xavier Bower